{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PI3K-AKT", "anti-inflammatory", "ardisiacrispin B", "metabolites", "network pharmacology"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38069381", "DateCompleted": {"Year": "2023", "Month": "12", "Day": "16"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "12", "Day": "02"}], "Language": ["eng"], "ELocationID": ["17059", "10.3390/ijms242317059"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "24", "Issue": "23", "PubDate": {"Year": "2023", "Month": "Dec", "Day": "02"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Metabolites-Based Network Pharmacology to Preliminarily Verify In Vitro Anti-Inflammatory Effect of Ardisiacrispin B.", "Abstract": {"AbstractText": ["<i>Ardisiae Crenatae Radix</i> is an ethnic medicinal herb with good anti-inflammatory activity. Ardisiacrispin B is one of the main components in <i>Ardisiae Crenatae Radix</i> extract, with a content of up to 16.27%, and it may be one of the pharmacological components through which <i>Ardisiae Crenatae Radix</i> exerts anti-inflammatory activity. At present, reports on ardisiacrispin B mainly focus on anti-tumor effects, and there have been no reports on anti-inflammatory activities. As a triterpenoid saponin, due to its large molecular weight and complex structure, the composition of substances that function in the body may include other forms after metabolism, in addition to compounds with original structures. Exploring the anti-inflammatory effects on the prototypes and metabolites of the compound may provide a more comprehensive response to the characteristics of ardisiacrispin B's anti-inflammatory action. In this study, ardisiacrispin B was analyzed for metabolites to explore its metabolic processes in vivo. Subsequently, the anti-inflammatory effects of the prototypes and metabolites were further analyzed through network pharmacology, with the expectation of discovering the signaling metabolic pathways through which they may act. Finally, the anti-inflammatory effects of ardisiacrispin B in vitro and the effects on key signaling pathways at the protein level were explored. The results of this study showed that the isolated compounds were confirmed to be ardisiacrispin B. After the metabolite analysis, a total of 26 metabolites were analyzed, and the metabolism process in rats mainly involves oxidation, dehydration, glucuronide conjugation, and others. Speculation as to the anti-inflammatory molecular mechanisms of the prototypes and metabolites of ardisiacrispin B revealed that it may exert its anti-inflammatory effects mainly by affecting the PI3K-AKT pathway. Further anti-inflammatory mechanisms demonstrated that ardisiacrispin B had a good anti-inflammatory effect on LPS-induced RAW264.7 cells and a strong inhibitory effect on NO, TNF-\u03b1, and IL-1\u03b2 release in cells. Furthermore, it had significant inhibitory effects on the expression of PI3K, P-PI3K, AKT, and P-AKT. This study supplements the gaps in the knowledge on the in vivo metabolic process of ardisiacrispin B and explores its anti-inflammatory mechanism, providing an experimental basis for the development and utilization of pentacyclic triterpenoids."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medicine, Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Zhou", "ForeName": "Wen", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Yang", "ForeName": "Guixiang", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wen", "ForeName": "Yushuang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Xiao", "ForeName": "Qian", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Sun", "ForeName": "Le", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Gong", "ForeName": "Zipeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Basic Medicine, Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Wang", "ForeName": "Yonglin", "Initials": "Y"}], "GrantList": [{"GrantID": "U1812403-5", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "[2023]006", "Agency": "Guizhou Science and Technology Department", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "112766-96-8", "NameOfSubstance": "ardisiacrispin B"}, {"RegistryNumber": "EC 2.7.1.-", "NameOfSubstance": "Phosphatidylinositol 3-Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": [], "DescriptorName": "Network Pharmacology"}, {"QualifierName": ["chemistry"], "DescriptorName": "Saponins"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tao Q., Li J. Progress on the research of inflammation and disease. J. Tradit. Chin. Vet. Med. 2023;42:34\u201343."}, {"Citation": "Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428\u2013435. doi: 10.1038/nature07201.", "ArticleIdList": ["10.1038/nature07201", "18650913"]}, {"Citation": "Kang Y., Wu G., Li L., Gan J. Study on chemical constituents and anti-inflammatory activities of sesterterpenoids of Dactylospongia elegans from the South China Sea. Nat. Prod. Res. Dev. 2023;35:1357\u20131363."}, {"Citation": "Jing B., Liu M., Yang L., Cai H.Y., Chen J.B., Li Z.X., Kou X., Wu Y.Z., Qin D.J., Zhou L., et al. Characterization of naturally occurring pentacyclic triterpenes as novel inhibitors of deubiquitinating protease USP7 with anticancer activity in vitro. Acta Pharmacol. Sin. 2018;39:492\u2013498. doi: 10.1038/aps.2017.119.", "ArticleIdList": ["10.1038/aps.2017.119", "PMC5843828", "29168472"]}, {"Citation": "Wei C., Xiao J., Xiao S., Cui P., Liu X. Progress in the study of natural pentacyclic triterpenoids with antibacterial activity. Chin. Tradit. Pat. Med. 2023;45:1231\u20131240."}, {"Citation": "Xiao S., Wang H., Wang Q., Han X., Xu R., Meng K., Tian Z., Zhang L., Zhou D. Recent progresses on pentacyclic triterpene-based antiviral agents. Sin. Chim. 2015;45:865\u2013883."}, {"Citation": "Zhou W., Huang Y., Hu X., Yuan J., Song Z., Liu B., Li L. Chemical constituents of triterpenoids from Sabia Discolor Dunnandwith Hypoglycemic Activity. J. Nanning Norm. Univ. (Nat. Sci. Ed.) 2023;40:73\u201381."}, {"Citation": "Ao Y., Feng C., Wu Y., Wu J., Wu J. Protective effect of total triterpenoids from Ganderma lucidium on acetaminophen induced liver injury in rats. Strait Pharm. J. 2022;34:8\u201312."}, {"Citation": "Sheng H., Sun H. Synthesis, biology and clinical significance of pentacyclic triterpenes: A multi-target approach to prevention and treatment of metabolic and vascular diseases. Nat. Prod. Rep. 2011;28:543\u2013593. doi: 10.1039/c0np00059k.", "ArticleIdList": ["10.1039/c0np00059k", "21290067"]}, {"Citation": "Shanmugam M.K., Nguyen A.H., Kumar A.P., Tan B.K., Sethi G. Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancer. Cancer Lett. 2012;320:158\u2013170. doi: 10.1016/j.canlet.2012.02.037.", "ArticleIdList": ["10.1016/j.canlet.2012.02.037", "22406826"]}, {"Citation": "Zhang B.W., Xing Y., Wen C., Yu X.X., Sun W.L., Xiu Z.L., Dong Y.S. Pentacyclic triterpenes as \u03b1-glucosidase and \u03b1-amylase inhibitors: Structure-activity relationships and the synergism with acarbose. Bioorg. Med. Chem. Lett. 2017;27:5065\u20135070. doi: 10.1016/j.bmcl.2017.09.027.", "ArticleIdList": ["10.1016/j.bmcl.2017.09.027", "28964635"]}, {"Citation": "Commission C.P. Pharmacopoeia of the People\u2019s Republic of China 2020: Part One. China Medical Science Press; Beijing, China: 2020. p. 143."}, {"Citation": "Qiu D. Chinese Herbal Medicine Miao Medicine Volume. Guizhou Science and Technology Publishing House Co., Ltd.; Guiyang, China: 2005. pp. 267\u2013269."}, {"Citation": "Zhou W. Ph.D. Thesis. Guizhou Medical University; Guiyang, China: 2023. Study on the Pharmacodynamic Material Basis and Mechanism of the Anti Acute Lung Injury Effect of Chinese Medicine Ardisia crenata Sims in Rats."}, {"Citation": "Li Y., Xia B., Long Q., Zhang G., Zha J., Wang A., Wang Y. Determination of the content of the main active components of Ardisiae Crenatae Radix. Lishizhen Med. Mater. Med. Res. 2011;22:1929\u20131931."}, {"Citation": "Shen Y., Chen J., Xu J., Guan B., Luo Z. Effect of Bergenin on the expression of IL-6, TNF-\u03b1 and NF-\u03baB in RAW264.7 cells induced by lipopolysaccharide. J. Chin. Med. Mater. 2012;35:1660\u20131662."}, {"Citation": "Arfan M., Amin H., Khan N., Khan I., Saeed M., Khan M.A., Fazal-ur-Rehman Analgesic and anti-inflammatory activities of 11-O-galloylbergenin. J. Ethnopharmacol. 2010;131:502\u2013504. doi: 10.1016/j.jep.2010.06.040.", "ArticleIdList": ["10.1016/j.jep.2010.06.040", "20603209"]}, {"Citation": "Mbaveng A.T., Ndontsa B.L., Kuete V., Nguekeu Y.M.M., \u00c7elik \u0130., Mbouangouere R., Tane P., Efferth T. A naturally occuring triterpene saponin ardisiacrispin B displayed cytotoxic effects in multi-factorial drug resistant cancer cells via ferroptotic and apoptotic cell death. Phytomedicine. 2018;43:78\u201385. doi: 10.1016/j.phymed.2018.03.035.", "ArticleIdList": ["10.1016/j.phymed.2018.03.035", "29747757"]}, {"Citation": "Sparg S.G., Light M.E., van Staden J. Biological activities and distribution of plant saponins. J. Ethnopharmacol. 2004;94:219\u2013243. doi: 10.1016/j.jep.2004.05.016.", "ArticleIdList": ["10.1016/j.jep.2004.05.016", "15325725"]}, {"Citation": "Chang H.T., Kong W.L., Tu P.F. Chemical and pharmacological advances of study on Lysimachia. Chin. J. Chin. Mater. Med. 2004;29:295\u2013298.", "ArticleIdList": ["15706860"]}, {"Citation": "Huang X., Yang R. Progress in the triterpenoids from the Genus Lysimachia L. J. Trop. Subtrop. Bot. 2007;15:175\u2013182."}, {"Citation": "Ni M., Han L. Chemical constituents of Ardisia crenata. Chin. J. Chin. Mater. Med. 1988;13:33\u201334; discussion 59.", "ArticleIdList": ["3255528"]}, {"Citation": "Liu D. Ph.D. Thesis. Shenyang Pharmaceutical University; Shenyang, China: 2004. Studies on the Bioactive Constituents of Ardisia crenata Sims and Bulbophillum odoratissimum Lindl."}, {"Citation": "Cai J. Ph.D. Thesis. Guangzhou University of Chinese Medicine; Guangzhou, China: 2012. Study on Chemical Constituents and Antitumor Activity of Ardisia crenata Root Ardisia crenata Sims and Cajanus cajan Leaf."}, {"Citation": "Maotian W., Xiongtai G., Xiuwen H., Shanhai H. A new triterpenoid saponin from Ardisia crenata. Planta Med. 1992;58:205\u2013207. doi: 10.1055/s-2006-961430.", "ArticleIdList": ["10.1055/s-2006-961430", "1529032"]}, {"Citation": "Jia Z., Koike K., Nikaido T., Ohmoto T. Two novel triterpenoid pentasaccharides with an unusual glycosyl glycerol side chain from Ardisia crenata. Tetrahedron. 1994;50:11853\u201311864. doi: 10.1016/S0040-4020(01)89300-5.", "ArticleIdList": ["10.1016/S0040-4020(01)89300-5"]}, {"Citation": "Jia Z., Koike K., Ohmoto T., Ni M. Triterpenoid saponins from Ardisia crenata. Phytochemistry. 1994;37:1389\u20131396. doi: 10.1016/S0031-9422(00)90418-7.", "ArticleIdList": ["10.1016/S0031-9422(00)90418-7", "7765756"]}, {"Citation": "Jia Z., Koike K., Nikaido T., Ohmoto T., Ni M. Triterpenoid saponins from Ardisia crenata and their inhibitory activity on cAMP phosphodiesterase. Chem. Pharm. Bull. 1994;42:2309\u20132314. doi: 10.1248/cpb.42.2309.", "ArticleIdList": ["10.1248/cpb.42.2309", "7859330"]}, {"Citation": "Zheng Z.F., Xu J.F., Feng Z.M., Zhang P.C. Cytotoxic triterpenoid saponins from the roots of Ardisia crenata. J. Asian Nat. Prod. Res. 2008;10:833\u2013839. doi: 10.1080/10286020802102568.", "ArticleIdList": ["10.1080/10286020802102568", "18985494"]}, {"Citation": "Song N.N., Yang L.M., Zhang M.J., An R.F., Liu W., Huang X.F. Triterpenoid saponins and phenylpropanoid glycoside from the roots of Ardisia crenata and their cytotoxic activities. Chin. J. Nat. Med. 2021;19:63\u201369. doi: 10.1016/S1875-5364(21)60007-9.", "ArticleIdList": ["10.1016/S1875-5364(21)60007-9", "33516453"]}, {"Citation": "Ye H., Zhou Y., Liao Z., Yin X., Wei X., Lei C., Zhou Y. Isolation and identification of triterpenoids from the roots of Ardisia crenata var. bicolor. J. Chin. Med. Mater. 2022;45:346\u2013350."}, {"Citation": "Han L., Ni M. Chemical constituents of Ardisia crenata. Chin. J. Chin. Mater. Med. 1989;14:33\u201335; discussion 58\u201359."}, {"Citation": "Li X., Shi H., Ding J., Feng T., Liu X., Liu C., Zhou Y. Analysis of chemical constituents as flavonoids and coumarins in Radix Ardisiae from different sources. Chin. Pharm. 2021;32:443\u2013452."}, {"Citation": "Qi X. Master\u2019s Thesis. Henan University; Zhengzhou, China: 2012. Study on the Chmistry Constituents and Bioactivity of Ardisia crenata Sims and Pholidota cantonensis Rolfe."}, {"Citation": "Zhao O., Du Y., Ban D., Wei W. Study on bioactive components of Ardisia crispa (Thunb.) DC. of Miao Nationality Herba (\u2160) Hubei Agric. Sci. 2013;52:4723\u20134725, 4747."}, {"Citation": "Chen S., Hu W., Huang Y., Jiang X., Wang Z. Preliminary analysis on chemical compositions of Ardisia crenata. Anhui Agric. Sci. Bull. 2007;13:152\u2013153."}, {"Citation": "Zhen H. Separation of saponins from Ardisia crenata by RP-HPLC. Chin. Tradit. Herb. Drugs. 2009;40:898\u2013900."}, {"Citation": "Yang S., Yu Z., Wang L., Yuan T., Wang X., Zhang X., Wang J., Lv Y., Du G. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition. J. Ethnopharmacol. 2017;200:147\u2013155. doi: 10.1016/j.jep.2017.02.013.", "ArticleIdList": ["10.1016/j.jep.2017.02.013", "28192201"]}, {"Citation": "Jansakul C., Baumann H., Kenne L., Samuelsson G. Ardisiacrispin A and B, two utero-contracting saponins from Ardisia crispa. Planta Med. 1987;53:405\u2013409. doi: 10.1055/s-2006-962758.", "ArticleIdList": ["10.1055/s-2006-962758", "3432422"]}, {"Citation": "Sui Y. Master\u2019s Thesis. Shenyang Pharmaceutical University; Shenyang, China: 2007. Microbial Transformation of Ardisiacrispin A and B."}, {"Citation": "Han M., Sha X., Wu Y., Fang X. Oral absorption of ginsenoside Rb1 using in vitro and in vivo models. Planta Med. 2006;72:398\u2013404. doi: 10.1055/s-2005-916211.", "ArticleIdList": ["10.1055/s-2005-916211", "16557452"]}, {"Citation": "Liang M.J., Zhang W.D., Zhang C., Liu R.H., Shen Y.H., Li H.L., Wang X.L., Wang X.W., Zhu J.B., Chen C.L. Quantitative determination of the anticancer agent tubeimoside I in rat plasma by liquid chromatography coupled with mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007;845:84\u201389. doi: 10.1016/j.jchromb.2006.07.053.", "ArticleIdList": ["10.1016/j.jchromb.2006.07.053", "16931181"]}, {"Citation": "Zhang J., Xiong Y. Advances in studies on absorption characteristics of pentacyclic triterpenes. Chin. Tradit. Herb. Drugs. 2009;40:1505\u20131508."}, {"Citation": "Ban Y., Chen R., Zhang Y., Zhang L., Liu W., Zhu G., Tang L. Advances in studies on oral absorption and metabolism of pentacyclic triterpenoids. Chem. Reag. 2021;43:906\u2013916."}, {"Citation": "Hattori M., Sakamoto T., Kobashi K., Namba T. Metabolism of glycyrrhizin by human intestinal flora. Planta Med. 1983;48:38\u201342. doi: 10.1055/s-2007-969875.", "ArticleIdList": ["10.1055/s-2007-969875", "6611743"]}, {"Citation": "Paek I.B., Moon Y., Kim J., Ji H.Y., Kim S.A., Sohn D.H., Kim J.B., Lee H.S. Pharmacokinetics of a ginseng saponin metabolite compound K in rats. Biopharm. Drug Dispos. 2006;27:39\u201345. doi: 10.1002/bdd.481.", "ArticleIdList": ["10.1002/bdd.481", "16302287"]}, {"Citation": "Zhou W., Feng M.Q., Li J.Y., Zhou P. Studies on the preparation, crystal structure and bioactivity of ginsenoside compound K. J. Asian Nat. Prod. Res. 2006;8:519\u2013527. doi: 10.1080/10286020500208600.", "ArticleIdList": ["10.1080/10286020500208600", "16931427"]}, {"Citation": "Choi K., Choi C. Proapoptotic ginsenosides compound K and Rh enhance Fas-induced cell death of human astrocytoma cells through distinct apoptotic signaling pathways. Cancer Res. Treat. 2009;41:36\u201344. doi: 10.4143/crt.2009.41.1.36.", "ArticleIdList": ["10.4143/crt.2009.41.1.36", "PMC2699093", "19688070"]}, {"Citation": "Li C., Gao H., Feng X., Bi C., Zhang J., Yin J. Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-\u03baB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells. J. Biochem. Mol. Toxicol. 2020;34:e22597. doi: 10.1002/jbt.22597.", "ArticleIdList": ["10.1002/jbt.22597", "32762018"]}, {"Citation": "Yao H., Wan J.Y., Zeng J., Huang W.H., Sava-Segal C., Li L., Niu X., Wang Q., Wang C.Z., Yuan C.S. Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer. Oncol. Lett. 2018;15:8339\u20138348. doi: 10.3892/ol.2018.8414.", "ArticleIdList": ["10.3892/ol.2018.8414", "PMC5950138", "29805567"]}, {"Citation": "Acosta-Martinez M., Cabail M.Z. The PI3K/Akt Pathway in Meta-Inflammation. Int. J. Mol. Sci. 2022;23:15330. doi: 10.3390/ijms232315330.", "ArticleIdList": ["10.3390/ijms232315330", "PMC9740745", "36499659"]}, {"Citation": "Wang J., Hu K., Cai X., Yang B., He Q., Wang J., Weng Q. Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm. Sin. B. 2022;12:18\u201332. doi: 10.1016/j.apsb.2021.07.023.", "ArticleIdList": ["10.1016/j.apsb.2021.07.023", "PMC8799876", "35127370"]}, {"Citation": "Zhu K., Wu Y., He P., Fan Y., Zhong X., Zheng H., Luo T. PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer. Cells. 2022;11:2508. doi: 10.3390/cells11162508.", "ArticleIdList": ["10.3390/cells11162508", "PMC9406657", "36010585"]}, {"Citation": "Peng J., Xiao X., Li S., Lyu X., Gong H., Tan S., Dong L., Sanders Y.Y., Zhang X. Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway. Exp. Gerontol. 2023;172:112085. doi: 10.1016/j.exger.2023.112085.", "ArticleIdList": ["10.1016/j.exger.2023.112085", "36623738"]}, {"Citation": "Li Q., Li Z., Luo T., Shi H. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy. Mol. Biomed. 2022;3:47. doi: 10.1186/s43556-022-00110-2.", "ArticleIdList": ["10.1186/s43556-022-00110-2", "PMC9768098", "36539659"]}, {"Citation": "Duan H., Li M., Liu J., Sun J., Wu C., Chen Y., Guo X., Liu X. An Integrated Approach Based on Network Analysis Combined with Experimental Verification Reveals PI3K/Akt/Nrf2 Signaling Is an Important Way for the Anti-Myocardial Ischemia Activity of Yi-Qi-Tong-Luo Capsule. Front. Pharmacol. 2022;13:794528. doi: 10.3389/fphar.2022.794528.", "ArticleIdList": ["10.3389/fphar.2022.794528", "PMC8889021", "35250556"]}, {"Citation": "Meng L.Q., Yang F.Y., Wang M.S., Shi B.K., Chen D.X., Chen D., Zhou Q., He Q.B., Ma L.X., Cheng W.L., et al. Quercetin protects against chronic prostatitis in rat model through NF-\u03baB and MAPK signaling pathways. Prostate. 2018;78:790\u2013800. doi: 10.1002/pros.23536.", "ArticleIdList": ["10.1002/pros.23536", "29654614"]}, {"Citation": "Li M., Lu G., Hu J., Shen X., Ju J., Gao Y., Qu L., Xia Y., Chen Y., Bai Y. EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy. Stem Cell Rep. 2016;6:396\u2013410. doi: 10.1016/j.stemcr.2016.01.011.", "ArticleIdList": ["10.1016/j.stemcr.2016.01.011", "PMC4788774", "26905199"]}, {"Citation": "He L., Pan Y., Yu J., Wang B., Dai G., Ying X. Decursin alleviates the aggravation of osteoarthritis via inhibiting PI3K-Akt and NF-kB signal pathway. Int. Immunopharmacol. 2021;97:107657. doi: 10.1016/j.intimp.2021.107657.", "ArticleIdList": ["10.1016/j.intimp.2021.107657", "33878544"]}, {"Citation": "Zhong J., Ding S., Zhang X., Di W., Wang X., Zhang H., Chen Y., Zhang Y., Hu Y. To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway. Front. Biosci. (Landmark Ed.) 2023;28:37. doi: 10.31083/j.fbl2802037.", "ArticleIdList": ["10.31083/j.fbl2802037", "36866550"]}, {"Citation": "Li C., Wang Z., Zhu Y. Progress in mechanisms research of lipoplysaccharide-induced acute lung injury. Chin. Med. Pharm. 2011;1:47\u201349."}, {"Citation": "Lu L., Zhang L. Development on pathogenesis of lipopolysaccharide-induced acute lung injury. Med. Recapitul. 2010;16:170\u2013173."}, {"Citation": "Song Z. Research progress of dexamethasone in the mechanism of lung protection in acute lung injury. J. Mod. Med. Health. 2017;33:2143\u20132146."}, {"Citation": "Meduri G.U., Golden E., Freire A.X., Taylor E., Zaman M., Carson S.J., Gibson M., Umberger R. Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest. 2007;131:954\u2013963. doi: 10.1378/chest.06-2100.", "ArticleIdList": ["10.1378/chest.06-2100", "17426195"]}, {"Citation": "Zha J. Master\u2019s Thesis. Guiyang Medical College; Guiyang, China: 2012. Study on the Quality Evaluation of Hmong Medicine Ardisia crenata Sims."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "10", "Day": "12"}, {"Year": "2023", "Month": "11", "Day": "22"}, {"Year": "2023", "Month": "11", "Day": "28"}, {"Year": "2023", "Month": "12", "Day": "17", "Hour": "9", "Minute": "43"}, {"Year": "2023", "Month": "12", "Day": "9", "Hour": "10", "Minute": "45"}, {"Year": "2023", "Month": "12", "Day": "9", "Hour": "1", "Minute": "16"}, {"Year": "2023", "Month": "12", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["38069381", "PMC10707123", "10.3390/ijms242317059", "ijms242317059"]}}], "PubmedBookArticle": []}